日本における再発性脳卒中に対するスタチン治療に関するhsCRP研究（J-STARS hsCRP）

基本情報

NCT ID

NCT00361699

ステータス

完了

試験のフェーズ

第3相

試験タイプ

介入

目標被験者数

1,095

治験依頼者名

Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan

概要

Inhibition of 3-hydroxy-3-methylglutaryl-coenzyme A(HMG-CoA) reductase can play a role in preventing recurrent vascular events from ischemic heart disease patients, whose mechanism consists in not only the reduction of serum lipid level but also anti-inflammatory effects. Serum high sensitive CRP is known to be a predictor of cardiovascular events independent of other conventional risk factors. The present substudy examine whether such pleiotrophic effect of HMG-CoA reductase inhibitor (statin) which decreases high sensitive CRP would be observed in the post-ischemic stroke patients who have already been registered in the J-STARS, and the relationship the values of high sensitive CRP and recurrence of stroke.

対象疾患

介入

依頼者（Sponsor）

実施施設 (2)